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Session: Regenerative Medicine 107also be involved in the physiological and pathological process of articular
cartilage.
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Introduction: Wrist chondral defect is a common cause of persistent joint
pain, which may lead to functional impairments including reduced range of
motion and diminished grip strength, affecting working ability and quality
of life. There are various reported surgical treatment regimens but their
effectiveness remains controversial due to the inherently poor regeneration
ability of cartilage. Bone marrow-derived mesenchymal stem cells (MSC) are
reported extensively to promote the regeneration of articular cartilage in
various chondral defect and osteoarthritis animal models. While translation
studies are on-going in knee OA, it is of clinical interest to explore the poten-
tial effectiveness of MSC therapy for the treatment of wrist chondral defect.
As the first local MSC trial for chondral defect, we aimed to examine the
feasibility and the safety, and to obtain data for sample size estimation for
future study.
Subjects and methods: In this phase I single-arm trial, 10 patients (18 to 75
years old) with persistent post-traumatic chronic wrist pain, with imaging
and previous arthroscopic evidence of wrist carpal bone chondral defects
who opted for active treatment were invited to join (CREC Ref No. 2014.291-
T). After arthroscopic washout and debridement, 10mL bone marrow was aspi-
rated and subjected to the isolation and expansion of MSC cells in a certified
clean room (ISO class 7). The MSC was characterized with a colony forming
unit (CFU) assay, surface phenotypes (CD45, CD14, CD19, CD34, CD73, CD105,
CD44, CD29, CD90, and HLA-DR), and a multipotent differentiation assay ac-
cording to the International Society for Cellular Therapy guidelines. One month
after bone marrow aspiration, characterised autologous MSCs (1 million cell per
mL saline) with viability over 90% and clean from microbiological tests were
injected back into the wrist joint of the patient. One-year follow-up assess-
ments including functional wrist performance score and pain score, and other
secondary assessments were carried out by trained personnel. The spread of
data was tested for normality. Changes from baseline (pre-op) in all the mea-
surements were determined with a t-test or Wilcoxon sign rank test where
appropriate. Missing data was replaced with imputation under a missing-at-
random assumption. Differences were considered statistically significant when
p < 0.05 (SPSS V19).
Results: Six patients (5 male and 1 female), mean age of 38.5 years old fulfilling
the inclusion and exclusion criteria were recruited during the reported period
(January to December 2015). All procedures, including bone marrow aspiration,
arthroscopic debridement, and intra-articular MSC injection, were uneventful
and there were no signs of infection and nil complications noted or
reported. It was practical to expand MSCs in vitro to a sufficient number for
characterisation and injection in one month. Till now, six-month follow up
data indicated the potential therapeutic effect of intra-articular MSC injection
at single dose, as shown by numerical improvement in performance score and
pain score.
Discussion and conclusion: This pilot clinical trial shows the safety and potential
therapeutic effect of single dose autologous bone marrow-derived MSCs on persis-
tent wrist chondral defect. Additional data from the second phase follow-up will
provide more insight into the treatment of wrist chondral defect with MSCs.
http://dx.doi.org/10.1016/j.jot.2016.06.117358
OPTIMISATION OF CULTURE CONDITIONS FOR MAINTAINING PORCINE INDUCED
PLURIPOTENT STEM CELLS
Yi Gao
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Ground state porcine induced pluripotent stem cells (piPSCs), which retain the
potential to generate chimeric animal and germline transmission, are difficult to
produce. This study investigated morphological and biological progression at the
early stage of porcine somatic cell reprogramming and explored suitable
conditions to increase the induction efficiency of piPSCs. A cocktail of defined
transcription factors was used to generate piPSCs. The amphotropic retrovirus,
which carried human OCT4 (O), SOX2 (S), KLF4 (K), C-MYC (M), TERT (T), and
GFP were used to infect porcine embryonic fibroblasts (PEFs). The number ofclones derived from OSKM (4F) and OSKMT (4F + T) was significantly higher than
that from SKM (3F) and SKMT (3F + T), suggesting that OCT4 played a critical role
in regulating porcine cell reprogramming. The number of alkaline phosphatase
positive clones from a medium with leukaemia inhibitory factor (LIF) and basic
fibroblast growth factor (bFGF) (M1 medium) was significantly higher than that
with insulin and 2i PD0325901/CHIR99021 (M2 medium), indicating that insulin
and 2i could not effectively maintain piPSC propagation. In the M1 medium,
piPSC lines could not maintain the typical self-renewal morphology on gelatin-
coated and Matrigel-coated plates. Without the mouse embryonic fibroblast
(MEF) feeder, piPSCs started to simultaneously differentiate. Based on the
potential for self-renewal and activation of pluripotent markers, we found that
the culture condition of 4F + T plus LIF and bFGF plus MEF feeder promoted PEF
reprogramming more efficiently than the other conditions tested. Two
piPSC lines (IB-1 and IB-2) were derived and maintained for up to 20 passages
in vitro.
http://dx.doi.org/10.1016/j.jot.2016.06.118405
INJECTABLE AND ROBUST BIOPOLYMER-BASED SUPRAMOLECULAR HYDROGELS
FOR REGENERATIVE MEDICINE
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Osteoarthritis (OA), which is symptomised as progressive degradation of
articular cartilage in human diarthrodial joints, has become one of most
prevalent, debilitating diseases in modern society. To address the increasing
clinical demand for more effective treatment of OA, significant progress has
been made in biotechnology, especially in the field of biomaterials. In the most
recent decade, increasing research emphasis has been placed on the “bio” part
of biomaterials. In our lab, we have shown that functionalisation of the
hydrogels with biomimetic peptides promotes the differentiation of the hMSCs.
In addition to the biofunctionalisation, the physical functions of the bio-
materials are also critical to the successful translation of biomaterials to
clinical treatment of cartilage diseases. Although biopolymer-based chemical
hydrogels, with biopolymers covalently crosslinked, have been widely used as
scaffolds for tissue engineering due to good stability, their permanent network
structures and brittleness limit their applications in repairing load-bearing
tissues, such as cartilage. In contrast, biopolymer-based supramolecular hydro-
gels, which are usually formed via self-assembly of physically interacting
biopolymers are usually weak, as shown in “inverted vials”, instead of
freestanding 3D constructs and they are less stable than chemical hydrogels.
Herein, we describe a novel host-guest macromer (HGM) approach for prepa-
ration of biopolymer-based freestanding supramolecular hydrogels. We have
developed a series of injectable hydrogels with unique properties such as
resilient mechanical property, bioadhesiveness, injectability, and promoting
recruitment of endogenous cells that are desirable for potential clinical
applications in the regeneration of soft musculoskeletal tissues such as
cartilage, meniscus, and intervertebral discs.
http://dx.doi.org/10.1016/j.jot.2016.06.119410
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Introduction: Mesenchymal stem cells (MSCs) have emerged as a clinically relevant
cell source for regenerative medicine, especially for cartilage repair; however, it
still remains a challenge to recapitulate the functional properties of native artic-
ular cartilage using only MSCs. In vitro expansion of chondrocytes causes dediffer-
entiation. Lately, co-cultures of chondrocytes and bone marrow MSCs
demonstrated enhanced functional properties of engineered cartilage. In this
study, we aimed to assess the effect of co-culture of synovium-derived stem cells
(SDSCs) and chondrocytes on in vitro chondrogenesis in serum-free TGF-b supple-
mented medium.
Methods: Isolation and expansion of cells: Human SDSCs and chondrocytes were
isolated by sequential digestion from explants of total knee arthroplasty patients
and incubated at 37 C, 95 % humidity, and 5 % CO2 in standard culture medium. We
used passage 2 cells hereafter.
In vitro differentiation of cells: Expanded chondrocytes, SDSCs, and chondrocyte/
SDSCs (5105cells per pellet; co-culture ratio, 1:1) were cultured in chondrogenic
medium for 1, 7, 14, and 21 days. The SDSC and chondrocyte/SDSC mixed pellets
were cultured with the supplementation of 10 ng/mL of TGF-b1 and the chondro-
cyte pellets were cultured in chondrogenic medium only. The medium was
changed twice per week.
